Author Information
Cheng-yang Chou is a distinguished researcher affiliated with the Department of Obstetrics and Gynecology at the National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. His extensive work in the field of gynecology, particularly in ovarian cancer, has made significant impacts on both clinical and academic fronts.Research Contributions
Cheng-yang Chou has made substantial contributions to the understanding and treatment of ovarian cancer. His research spans various critical areas including the prediction of long-term prognoses in ovarian clear cell carcinoma, the modulation of cancer-associated fibroblasts, and the improvement of treatment efficacies of platinum-containing drugs in chemotherapy. His work often explores the molecular underpinnings of cancer cell behavior, such as the role of miR-335 in inhibiting aggressive phenotypes in ovarian cancer cells and the enhancement of migration abilities in chemoresistant ovarian cancer through store-operated Ca2+ entry. Cheng-yang Chou's studies also include real-world evaluations of adding bevacizumab to chemotherapy and the efficacy of PI3K/Akt inhibitors in ovarian cancer treatment.Aliases
Cheng-yang Chou is also known by several aliases in academic publications, including C-y. Chou, C. Y. Chou, Chen-yang Chou, C Y Chou, C. Chou, C.-y. Chou, and Cheng Yang Chou.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
3652 |
| h-index |
35 |
| Paper Count |
168 |
| Affiliation |
Department of Obstetrics and Gynecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. |
